Noticed bit of a vaccine rally among the travel stocks lately.
Casting net further a field for some growth stocks with good balance sheets having been subjected to similar downward pressure but not noticed by the market ran across A2M.
Broached 10 but looks like support in (maybe) so had a look at CLV, it lag trades A2M.
Got this wrong the other month when A2M issued guidance downgrade but if vaccine momentum is real both will benefit.
Hound on buy side @ 135 ish last few days for 20% on large dollars (for the garage)
See how we go, right on covid low double bottom
, CLV is a quality stock with good balance sheet just in wrong place at wrong time (covid, lack of diagou etc)
If you are looking for discounted quality worth a ponder, CLV will be worth multiples of 140 in the future, trick is to know when the future is, I don't so DYOR
View attachment 2946772
